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Abstract
Background: There is increasing interest in developing peer-led and 'expert patient'-type interventions,
particularly to meet the support and informational needs of those with long term conditions, leading to
improved clinical outcomes, and pressure relief on mainstream health services. There is also increasing
interest in telephone support, due to its greater accessibility and potential availability than face to face
provided support. The evidence base for peer telephone interventions is relatively weak, although such
services are widely available as support lines provided by user groups and other charitable services.
Methods/Design: In a 3-arm RCT, participants are allocated to either an intervention group with
Telecare service provided by a Diabetes Specialist Nurse (DSN), an intervention group with service
provided by a peer supporter (also living with diabetes), or a control group receiving routine care only.
All supporters underwent a 2-day training in motivational interviewing, empowerment and active listening
skills to provide telephone support over a period of up to 6 months to adults with poorly controlled type
2 diabetes who had been recommended a change in diabetes management (i.e. medication and/or lifestyle
changes) by their general practitioner (GP). The primary outcome is self-efficacy; secondary outcomes
include HbA1c, total and HDL cholesterol, blood pressure, body mass index, and adherence to treatment.
375 participants (125 in each arm) were sought from GP practices across West Midlands, to detect a
difference in self-efficacy scores with an effect size of 0.35, 80% power, and 5% significance level. Adults
living with type 2 diabetes, with an HbA1c > 8% and not taking insulin were initially eligible. A protocol
change 10 months into the recruitment resulted in a change of eligibility by reducing HbA1c to > 7.4%.
Several qualitative studies are being conducted alongside the main RCT to describe patient, telecare
supporter and practice nurse experience of the trial.
Discussion and implications of the research: With its focus on self-management and telephone peer
support, the intervention being trialled has the potential to support improved self-efficacy and patient
experience, improved clinical outcomes and a reduction in diabetes-related complications.
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Background
Numerous studies have reported the relationship between
self-management practice for long term conditions,
patient behavioural change and subsequent improvement
in physical and psychological well being and reduction in
health service resource use [1,2]. A review of 145 papers
on self management revealed a growing body of evidence
demonstrating that compared with standard care, self
management approaches improve knowledge, perform-
ance of self management behaviours, self efficacy and
health status including reduction in blood glucose levels,
calorific intake, weight and lowering serum cholesterol
[3].
About 2% of the UK population are diagnosed as having
diabetes, and the number is predicted to double to over 3
million by 2010 [4]. Diabetes is expensive, accounting for
8–9% of total health service costs in the UK. Much of this
relates to the costs of treating the complications of diabe-
tes, such as coronary heart disease and renal failure.
Adherence in diabetes has been reported as difficult and
complex [5], few patients taking their prescribed regimen
entirely as intended [6]. Effective diabetes self-manage-
ment training interventions have been developed, but the
challenge is how to deliver these in a way that is practical,
consistent, cost-effective, and acceptable to patients and
health care professionals in the 'real world' [7-9]. Adher-
ence can be increased by enabling patients to improve and
reinforce understanding, combined with recognition,
identification and resolution of obstacles to therapeutic
advice [9]. A productive time to intervene to promote
adherence is when a new therapy is introduced [10].
The role of the patient in diabetes self-management has
expanded beyond responsibility for personal care to
incorporate the role of educator. This latter role acknowl-
edges the value of diabetes patient knowledge and experi-
ence in the provision of effective education and support.
In the UK, in recent years the importance of developing
this role has been promoted by health policy. As indicated
within the Expert Patient Report [11] research findings
'display the ability of patients to successfully guide other
patients in becoming 'expert' in their own care and high-
light the value of patient knowledge as an educational and
communicative tool'. In line with these observations and
combined with the growing awareness of the benefits of
lay involvement, the telephone support system of care
being tested in this trial incorporated both peer and nurse
support.
A potential method of delivering self-management pro-
grammes, whether lay or health professional-led, is via tel-
ephone contact. A recent Cochrane review has shown that
telecommunication for patient care has been found to be
acceptable to patients [12]. While telephone contact with
patients is a common feature of diabetes specialist nurse
practice in the UK, the effectiveness of this is unknown
[13], as is the value of telephone support in diabetes care
provided by peer supporters. More frequent contact with
the healthcare provider may positively affect a patient's
adherence to self-management activities [13], enhance
autonomy and confidence in managing diabetes [14], and
help the healthcare provider and the patient to revise and
adjust diabetes management goals [15,16].
In summary, the behavioural change witnessed in patients
as a result of improved and supported self-management
practice has been associated with a range of physical and
psychological benefits. When triangulated with the
acceptability and cost effectiveness of telecare and the
increasing awareness of the lay advisor role in the success-
ful provision of support, the literature identifies a poten-
tially efficacious, cost effective and patient centred
method of enhancing self-management.
Intervention development and trial design
In line with the MRC framework for development and
evaluation of RCTs for complex interventions to improve
health [17], the current study proposal has incorporated
three key stages of research development. A theoretical
basis was established from relevant literature, feasibility
work was conducted to develop an understanding of the
intervention and its potential outcomes and finally an
exploratory trial is being undertaken to determine the
requirements of the design and the success of the research
strategy.
The feasibility study explored the acceptability and poten-
tial benefits of the proposed intervention via qualitative
and quantitative research and consultation with expert
health professionals [18]. A questionnaire was distributed
to 107 GP practices within the Warwick Diabetes Care
Research Framework. One hundred percent of responders
(N = 82) considered the diabetes telephone care service to
be 'highly' or 'very highly' important to the NHS, feasible
and of potential benefit to patients. Qualitative interviews
were conducted with 7 primary care and secondary care
diabetes health professionals. The provision of telephone
support to patients experiencing a change in treatment
within primary care was considered extremely beneficial
and currently, due to inadequate health service resources,
a goal which was not being achieved well in either second-
ary or primary care. Interviewees reported that although
telephone support is often provided from secondary care
by diabetes specialist nurses (DSN) when patients are first
changed to insulin, the short-term nature of this support
meant that it had limited effectiveness in assisting patients
with the long-term physical and psychological difficulties
of treatment change. Additionally, this support is gener-
ally not provided to patients experiencing a change fromTrials 2007, 8:18 http://www.trialsjournal.com/content/8/1/18
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diet to tablets or alteration in type of tablet. Interviewees
felt this to be an area requiring greater attention in partic-
ular relation to patient difficulty in establishing and main-
taining a successful medication regime within their day to
day routine.
A needs assessment was also undertaken of self-manage-
ment of people with a recent diagnosis of diabetes or
change in diabetes therapy [19]. The study comprised 6
focus groups conducted with 23 participants recruited
within the West Midlands through adverts in local news-
papers and leaflets placed in GP clinics. The results clearly
identified the perceived potential value of peer support
within diabetes patient care. Peer support, facilitated from
within the health care system, was felt to represent a valu-
able untapped resource for furthering and enabling self-
management education and support. In addition, expert
opinion was sought through the Warwick Diabetes Care
Advisory Board, a group of nationally recognised experts
of various disciplines related to diabetes care, chaired by
Professor Harry Keen. This strongly endorsed the use of
peer supporters to advise patients, in light of their knowl-
edge of the current inadequacies in care provision, in par-
ticular relation to the ever increasing pressure being
placed upon DSNs within secondary care.
Subsequently, a phase I exploratory trial was conducted to
test the key components of the telecare intervention
including training, recruitment, and practitioner role. The
trial consisted of two fully trained peer supporters provid-
ing telephone service (shortened version: 2 calls over a 10
day period) to diabetes patients from a single practice
experiencing a change in medication (tablet regime). The
peer supporters participated in a comprehensive motiva-
tional interviewing training programme. The trial was
conducted for 1 month and provided telecare support to
7 patients. Telephone record sheets were maintained
throughout to ensure consistency of support. Evaluation
telephone call interviews revealed that patients felt 'very
comfortable' discussing their diabetes care with a peer
supporter, were 'very satisfied' with the support received
and were happy to receive this support in the future.
Reported advantages included speaking to a non health
professional who understood diabetes, having someone
to listen and the provision of support during a period of
uncertainty regarding medication change. Positive out-
comes of the exploratory trial were also reported by partic-
ipating health care professionals and the peer supporters
who believed the success of the trial supported the impor-
tance of the main study.
Aims of the Trial
The hypotheses to be tested in this study are that telecare
motivational interviewing will be acceptable to patients
and primary care health professionals; will be associated
with improved social and psychological status; healthier
lifestyle choices; and enhanced satisfaction with care.
We propose to:
1. Determine the impact on quality of care, behavioural
change and patient responsiveness of a centralised, expert
telecare (nurse and peer-led motivational support by tele-
phone) intervention.
2. Compare the impact of nurse and peer supporter tele-
care provision against routine care.
3. Obtain clinical data as a means to identifying patterns
and trends to be used in conjunction with behavioural
change outcomes, in order to determine the value of
undertaking a full scale RCT of the cost and clinical effec-
tiveness of the intervention.
Methods/Design
This study is an RCT of three arms:
i. Telecare service provided by diabetes specialist nurses
ii. Telecare service provided by peer supporters
iii. Control group receiving routine care only
Randomisation to control or intervention will be carried
out at the patient level. Within the intervention group,
patients will be randomly allocated to either a nurse or
peer telephone supporter. To limit bias arising from
patients' perception of their randomisation, all patients
will receive at least one phone call. This should also
ensure that the referring healthcare practitioners are as
blinded as realistically possible. Patients will not be
informed about whether they are in the intervention or
control groups. The name, address, telephone number,
access times, current treatment, details of any recent
change in therapy (medication, diet, monitoring, and
physical activity programme) related to diabetes, together
with any provisos that were made, will be sent to the trial
centre by the referring GP/nurse.
Proposed Telecare Service
DSNs and peer supporters experienced in diabetes self
management will systematically provide telephone sup-
port and advice to patients referred from primary care
after a change in the patient's diabetes management
(medication and/or lifestyle changes) recommended by
their GP. It will be offered as an addition to routine care.
The supporters will work to a protocol that includes a
detailed enquiry into adherence to prescribed therapy,
identification of problems, and brief negotiation in which
realistic manageable goals for lifestyle change and over-Trials 2007, 8:18 http://www.trialsjournal.com/content/8/1/18
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coming barriers are agreed. The overarching aim of the tel-
ecare support is to reinforce the goals already established
between health professional and patient.
The supporters will be recruited using a specification that
sets out essential and desirable attributes established from
stakeholder consultation and user group involvement.
They will be trained using a 2-day programme developed
by Warwick Diabetes Care. The programme is based on
the theoretical background to successful behaviour
change as described by Anderson and Funnell [20] and
Rollnick et al [21] and practical counselling skills to
enhance people's own decision making [22]. The pro-
gramme includes training in empowerment, motivational
interviewing, active listening skills, a brief psychological
intervention that has been shown to be an effective strat-
egy to increase readiness to change, assessing readiness to
change, and the negotiation of agreed changes. Supporters
will subsequently obtain an understanding of the factors
that affect health behaviour, methods to assist others in
altering these behaviours, and mastering the application
of these techniques via telephone. Peer supporters, to fur-
ther enhance their experience of patient support provision
will attend a series of structured role-play sessions.
For patients in an intervention arm of the trial, the first tel-
ecare call will be made 3–5 days after referral from the
patient's GP. The telecare supporter will tailor (and docu-
ment) the frequency of subsequent calls to each patient's
needs. The 'standard package' will be offering subsequent
contact during the periods of days 7–10, 14–18, 28–35,
56–70, 120–150 but some patients will require more fre-
quent contact while others may want less. Before comple-
tion of each call, the telecare supporter will negotiate the
time of the next call. Supporters will routinely provide
feedback on all calls to the research team via a standard
form. However, if the telecare supporter feels more imme-
diate contact is required, they will follow a formal feed-
back process to the GP; for peer supporters this will be a
two stage process of referral to nurse and then, where
appropriate GP. The reasons for such contact will be doc-
umented. Discussion with diabetes specialist nurses who
had experience of telephone contact with patients sug-
gested that the mean follow-up call length will be 5–10
minutes. Hence, on average each patient within the inter-
vention groups will receive a total telecare intervention of
about 45 minutes duration.
Patients in the control group will receive a single call from
a researcher lasting approximately 10 minutes. This call
will inform the patient that s/he is allocated to the routine
care group, and that is the only phonecall s/he receives.
The patient will be encouraged to follow the medical
advice given to her/him by the GP/practice nurse.
Setting
The study is being undertaken within general practices
within the West Midlands South Strategic Health Author-
ity. This is a socio-economically and geographically
diverse region in central England in which to test uptake
and effectiveness of the intervention and trial methodol-
ogy. In all, 40 practices have agreed to participate. Train-
ing was given to a practice nurse and general practitioner
from each practice on how to manage patient recruitment,
inclusion and exclusion criteria, consenting, maintaining
subjects in the trial, collecting data etc.
Setting up the telecare intervention
Twelve DSNs and nine peer supporters have been
recruited using the DSN directory, Warwick Diabetes Care
User Group and an email support group hosted by Trefoil
Solutions to work as sessional telecare supporters for the
study. In addition to interest in the study, they need to be
willing to work flexible hours and be able to attend the
training programme outlined above. The telecare support-
ers will receive monthly email or telephone supervision
from their trainer to monitor workload, feasibility of the
intervention, adequacy of training, and discuss specific
patients presenting difficulties for the telecare supporter.
A proportion of the telecare interactions will be tape-
recorded. The tapes will be used to validate the data
recorded during telecare interactions by the supporter, as
a means to enhancing quality improvement of the inter-
vention and for training purposes. Consent will be sought
both before and after each taped interaction.
A trial centre will be established which supporters and
patients can access throughout the duration of the study.
Referral processes will be in place to respond to patient
concerns. All patient record files will be kept under lock
and key at the telecare centre and accessible only to the tel-
ecare service providers and the lead researchers. Wherever
possible, anonymised patient data will be used. Confiden-
tiality will be maintained and all provisions of the Data
Protection Act will be followed.
Inclusion/Exclusion Criteria
The inclusion/exclusion criteria were initially set as:
Eligible patients
Patients who have had a recent HbA1c greater than 8.0%
and been advised of the need to improve their glycaemic
control, with or without a change in prescribed tablet
based therapy.
Exclusions
Patients on insulin, lacking a telephone, and those with
severe accompanying disorders (e.g. mentally ill; severe
learning difficulties; severe hearing difficulties) or disor-
ders judged by the GP as likely to interfere with outcomeTrials 2007, 8:18 http://www.trialsjournal.com/content/8/1/18
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interpretation. Exclusions will not be made on the basis of
anticipated patient co-operation, except where there are
objective reasons for so doing.
10 months into the trial, the clinical threshold for inclu-
sion was lowered in response to requests from GPs to
allow patients with baseline HbA1c > 7.4% (as opposed to
the previous criteria of HbA1c > 8%) to become eligible
for telecare. This modification to the protocol is in line
with the current NHS targets (new GMS contract target is
7.4%) and the manner in which practices are organising
and delivering their care. The latest research evidence pub-
lished in the American journal Diabetes Care also supports
this change in eligibility criteria. In addition, the change
was supported by research findings published by Young et
al (2005) which reported significant improvement in
HbA1c values as a result of telecare for patient with base-
line HbA1c > 7% [23].
Recruitment of patients
At each practice site, the lead GP or practice nurse for dia-
betes is responsible for managing patient recruitment.
During the data collection period, all adult patients with
type 2 diabetes with an impending review appointment
who meet the inclusion criteria will be contacted by post
and invited to participate within the study. Participation
and consent are subsequently discussed with the referring
GP or nurse at the review appointment. Hence, the inten-
tion is that the intervention should be implemented sys-
tematically within the normal practice routine, as far as
possible. Patients will be provided with written informa-
tion about the study, and invited to give written consent
for inclusion.
Experiments Proposed Including End Points
The hypotheses to be tested are that the telecare interven-
tion compared with routine care alone will improve
adherence to the change in medication targeted; improve
clinical and psychological status; encourage healthier life-
style choices and enhance satisfaction with care. In addi-
tion, that it will be acceptable to patients and primary care
health professionals.
Baseline Data
In addition to the questionnaires outlined below, for
patients who consent to be randomised, sex, age, ethnic-
ity, diabetes history, most recent clinical parameters
(HbA1c, BP, BMI, total plasma cholesterol, HDL: total
cholesterol ratio, and plasma triglycerides), prescribed
medication, smoking status, phone number, access hours,
and any provisos requested by the patient will be recorded
on a pro forma at recruitment by practice staff. Patients
who do not wish to participate in the study will be asked
for consent to include their reasons for not doing so, and
their sex, age, ethnicity, most recent clinical parameters
and smoking status will be recorded. This will allow for
comparison between the characteristics of participants
and non-participants.
Outcome Data
All outcome data from patients in the intervention and
control groups are being collected at site level by a practice
nurse or GP, recorded on templates developed for the pur-
pose, and forwarded by post to the trial office. Patients in
the intervention groups will be asked to complete a 4 page
questionnaire after 3 and 6 months, while patients in the
control group will complete the questionnaire only at 6
months. The questionnaire incorporates The Problem
Areas in Diabetes Scale (PAID) [24], the Diabetes Manage-
ment Self-Efficacy Scale (DMSES) [25], the diabetes self-
care activities measure [26], the Perceived Therapeutic
Efficacy Scale (scale under development) [27], and an
acceptability of service provision measure. The question-
naire will be completed at the surgery and posted in a
reply paid envelope.
Clinical Data
Clinical data at baseline will be collected prior to patient
randomisation. Blood specimens for HbA1c assessment,
total and HDL cholesterol are being taken according to
local protocols either by practice staff or the local phlebot-
omy service. They are being analysed by the local hospital
based laboratory services routinely used by the practices,
blinded to patient group allocation. We will ensure that if
changes in standardisation occur during data collection
that, at each site, all data are reported according to the
same standard. Practices will arrange a 3 and 6 month
review appointment with patients in the intervention
group and a 6 month review for those in the control group
at which point clinical follow up data will be collected. A
reminder of forthcoming appointments will be distrib-
uted by the trial office to each participating practice 2
weeks before the appointment is due.
Content of Telecare Intervention
Telecare nurses and peer supporters will record the dates,
times and duration of calls made to each patient, and the
number of attempts required to make contact with the
patient on each occasion. The content of calls made to and
received from patients (including referrals) will be down-
loaded from the electronic template. Patient dropouts and
reasons for this will also be recorded.
Sample size
The sample size is based upon the primary outcome meas-
ure of self efficacy, measured using the DMSES and has
been constructed to detect a difference in the primary out-
comes of self efficacy perceptions and psychological
adjustment. A sample of at least 300 patients (minimum
100 in each arm) has been constructed to detect a differ-Trials 2007, 8:18 http://www.trialsjournal.com/content/8/1/18
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ence in self-efficacy scores with an effect size of 0.35, 80%
power at a level of 5% significance level [25]. Allowing for
an attrition rate of 25% from initial recruitment, we will
require 125 subjects in each arm (i.e. 375 participants in
total).
Ethics approval
The study has received approval from Warwickshire LREC
(reference number: RE 610).
Trial Analysis
Data will be entered in SPSS. A random 20% of the data
will be entered twice to check for discrepancies with the
original data. Descriptive methods will be used to demon-
strate the consistency of the three groups, describe partic-
ipant characteristics, to compare the refusers with the
study participants and report levels of participation and
drop out. Comparison of nurse and peer supporter out-
come data, experiences and feedback will be provided.
Analysis of variance will be used to evaluate baseline char-
acteristics of participants compared to non-participants,
overall significance of improvement across outcome
measures, and dropout versus maintainers. For each
patient, change in physiological measures from start to 6
months will be calculated and analysed using t-test for
matched groups for both intervention and control groups.
The magnitude of change in both primary and secondary
outcome measures will be estimated and the 95% confi-
dence intervals given. Formal Statistical Input: A research
fellow in medical statistics will provide statistical support
and advice throughout the study.
Qualitative studies
Several qualitative studies are being conducted in parallel
with the main RCT:
1. Telecare supporters' experience: telephone semi-struc-
tured interviews with the supporters (diabetes specialist
nurses and peer supporters) will be conducted one-year
into the intervention. The interviews will aim to capture
their experience of delivering the intervention, and the
impact of helping others on their own physical and psy-
chological well-being (as well as their professional prac-
tice, for nurses).
2. Patient experience: telephone semi-structured inter-
views will be undertaken with a purposive sample of
patients allocated to each intervention arm of the trial, to
include patients who have improved HbA1c from base-
line to 6 months together with others who have failed to
improve. The interview will explore participants' views
about the service, issues around the provider (e.g. credibil-
ity, trustworthiness, helpfulness), elements of the inter-
vention, and benefits of the service.
3. Referring healthcare professional experience: telephone
semi-structured interviews will be conducted with twelve
GPs and practice nurses following completion of the six-
month data collection, in order to capture their views on
self-management, experience of patient recruitment and
participation in the research study.
The interviews will be recorded and transcribed verbatim.
A thematic framework approach will be used to analyse
the data [28]. The framework approach is a systematic
process of analysing the data, following a clear procedure
and allowing the material to be categorised according to
key themes. First, in the familiarisation stage, a relevant
sample of tapes will be listened to, the transcripts will be
read, and notes will be made on key issues and recurrent
themes. In the second stage, the notes will be used to set
up a thematic framework, based on a priori issues (the
interview topic guide), as well as recurring views and
emergent issues raised by the participants. In the third
stage, the index will be applied to all interview transcrip-
tions, followed by the fourth stage, where data will be
rearranged according to themes (process known as chart-
ing). In a final stage, data will be mapped and interpreted.
The data will be analysed independently by 2 researchers.
Where disagreement occurs, consensus will be reached
through discussion.
Discussion
The Value of the Research to Public Health and Patient 
Care
It is anticipated that the provision of motivational telecare
support will enhance the self-management of patients
with type 2 diabetes leading to improved clinical and psy-
chological outcomes and reduction in the likelihood of
diabetic complications. In addition to the improvement
in individual patient care, the service could provide a cost
effective adjunct to routine care, alleviating the resource
pressures currently experienced within primary care and
secondary care practice while establishing a successful and
robust method of responding to the increasing prevalence
of diabetes.
The project, in light of its focus upon self-management,
peer involvement and telephone support has the potential
to demonstrate an approach that is relevant to realising
progress towards the achievement of the care targets in
relation to not only diabetes, but a range of long term con-
ditions. The intervention offers a valuable tool in dealing
with the difficulties and complications of long term con-
ditions, and as such might be applicable in a wide range
of settings.
The main trial started in autumn 2004, shortly after the
introduction of the new General Medical Services contract
for general practice and the implementation of the Qual-Trials 2007, 8:18 http://www.trialsjournal.com/content/8/1/18
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ity and Outcomes framework (QOF) [29]. The new GMS
contract substantially increased the workload for general
practitioners, making participation in research less attrac-
tive, and this has had an adverse impact on patient recruit-
ment. However, the QOF targets resulted in considerably
more data on diabetes care being routinely collected by
GPs for the annual QOF reports, and at the same time the
QOF introduce financial incentives to bring the patients'
HbA1c levels below the 7.4% threshold through the more
aggressive prescription of oral hypoglycaemic agents and
insulin. Together, this resulted in slow participant recruit-
ment for the trial, due to a reduction in the number of eli-
gible patients. In response, the clinical threshold for trial
inclusion was lowered to allow patients with baseline
HbA1c > 7.4% (as opposed to the previous criteria of
HbA1c > 8%) to become eligible for telecare, in line with
the manner in which practices are organising and deliver-
ing their care. The change in protocol mid-way through
the trial will have implications on the presentation of the
consort diagram and the interpretation of the study's find-
ings.
The qualitative studies conducted in parallel with the
main trial aim to capture the views of patients, supporters
and health care professionals on their involvement in the
study, satisfaction and benefits derived. It will enrich the
interpretation of the quantitative data obtained from the
main trial, by shedding light on the importance of various
components of this complex intervention. Together with
the quality assurance procedures, the qualitative studies
will help to inform future intervention delivery research,
particularly in the areas of patient and peer supporter
recruitment, training delivery, the use of the theoretical
framework within the intervention delivery, and the expe-
rience and potential benefits of telephone support for
both patients and the supporters.
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